Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Merrick

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
American Journal of Clinical Oncology|February 7, 2012
Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillanceAl V Taira, Gregory S Merrick, Abbey Bennett, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
Brachytherapy|March 13, 2012
Prognostic importance of tobacco use in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2008
Primary causes of death after permanent prostate brachytherapyNathan Bittner, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Urology|February 24, 2009
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMBNathan Bittner, Gregory S Merrick, Hugo Andreini, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidityZachariah A Allen, Gregory S Merrick, Wayne M Butler, et al.
Urology|February 20, 2004
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate glandJoseph G Donzella, Gregory S Merrick, David J Lindert, et al.
Urologic Nursing|August 31, 2006
Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 17, 2007
A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapyDaniel R Reed, Kent E Wallner, Gregory S Merrick, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
American Journal of Clinical Oncology|February 7, 2012
Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillanceAl V Taira, Gregory S Merrick, Abbey Bennett, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
Brachytherapy|March 13, 2012
Prognostic importance of tobacco use in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2008
Primary causes of death after permanent prostate brachytherapyNathan Bittner, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Urology|February 24, 2009
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMBNathan Bittner, Gregory S Merrick, Hugo Andreini, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidityZachariah A Allen, Gregory S Merrick, Wayne M Butler, et al.
Urology|February 20, 2004
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate glandJoseph G Donzella, Gregory S Merrick, David J Lindert, et al.
Urologic Nursing|August 31, 2006
Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 17, 2007
A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapyDaniel R Reed, Kent E Wallner, Gregory S Merrick, et al.
Pageof 19